100
Participants
Start Date
July 11, 2023
Primary Completion Date
April 2, 2026
Study Completion Date
March 30, 2032
LOU064 (blinded)
LOU064 (blinded) active treatment
placebo
matching active drug
RECRUITING
Novartis Investigative Site, Rosario
RECRUITING
Novartis Investigative Site, Utrecht
RECRUITING
Novartis Investigative Site, Cape Town
RECRUITING
Novartis Investigative Site, Bangkok
RECRUITING
Novartis Investigative Site, Bangkok
RECRUITING
Novartis Investigative Site, Berlin
RECRUITING
Allergy and Clinical Immunology Associates, Pittsburgh
RECRUITING
Novartis Investigative Site, Pavia
RECRUITING
Pediatric Dermatology of Miami at the Pediatric CoE, Coral Gables
RECRUITING
Novartis Investigative Site, Istanbul
RECRUITING
Novartis Investigative Site, Trieste
RECRUITING
Allergy and Asthma Specialist P S C, Owensboro
RECRUITING
Novartis Investigative Site, Parma
RECRUITING
Toledo Institute of Clinical Research, Toledo
RECRUITING
Novartis Investigative Site, Valencia
RECRUITING
Novartis Investigative Site, Münster
RECRUITING
Novartis Investigative Site, Florence
RECRUITING
Novartis Investigative Site, Siena
RECRUITING
Novartis Investigative Site, Mainz
RECRUITING
Endeavor Health, Glenview
RECRUITING
Novartis Investigative Site, Frankfurt am Main
RECRUITING
Novartis Investigative Site, Bari
RECRUITING
Novartis Investigative Site, Tübingen
RECRUITING
Allergy Asthma and Clinical Research, Oklahoma City
RECRUITING
RFSA Dermatology, San Antonio
RECRUITING
Novartis Investigative Site, Napoli
RECRUITING
Treasure Valley Medical Research, Boise
RECRUITING
Allergy Associates of Utah, Sandy City
RECRUITING
Novartis Investigative Site, Songkhla
RECRUITING
Allergy and Asthma Medical Group and Research Center, San Diego
RECRUITING
Kern Research, Bakersfield
RECRUITING
Novartis Investigative Site, Kuching
WITHDRAWN
Seattle Allergy and Asthma Rsch, Seattle
RECRUITING
Novartis Investigative Site, Beijing
RECRUITING
Novartis Investigative Site, Beijing
RECRUITING
Novartis Investigative Site, Singapore
RECRUITING
Novartis Investigative Site, Singapore
RECRUITING
Novartis Investigative Site, Guangdong
RECRUITING
Novartis Investigative Site, Chengdu
RECRUITING
Novartis Investigative Site, Hong Kong
RECRUITING
Novartis Investigative Site, Pokfulam
ACTIVE_NOT_RECRUITING
Novartis Investigative Site, Santiago
RECRUITING
Novartis Investigative Site, CABA
RECRUITING
Novartis Investigative Site, CABA
RECRUITING
Novartis Investigative Site, CABA
RECRUITING
Novartis Investigative Site, Montreal
RECRUITING
Novartis Investigative Site, Kitakyushu
RECRUITING
Novartis Investigative Site, Kamimashi-gun
RECRUITING
Novartis Investigative Site, Sakai
RECRUITING
Novartis Investigative Site, Izumo
RECRUITING
Novartis Investigative Site, Itabashi-ku
RECRUITING
Novartis Investigative Site, Deventer
RECRUITING
Novartis Investigative Site, Lodz
RECRUITING
Novartis Investigative Site, Olsztyn
RECRUITING
Novartis Investigative Site, Warsaw
RECRUITING
Novartis Investigative Site, Pretoria
RECRUITING
Novartis Investigative Site, Esplugues de Llobregat
RECRUITING
Novartis Investigative Site, Barcelona
RECRUITING
Novartis Investigative Site, Adana
RECRUITING
Novartis Investigative Site, Ankara
RECRUITING
Novartis Investigative Site, Peterborough
RECRUITING
Novartis Investigative Site, Manchester
RECRUITING
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY